CVS Health Stock Surges on 2025–2026 Guidance: Key News, Forecasts and Analysis Since November 21, 2025
CVS Health shares have surged about 70–80% year-to-date in 2025, trading near $80.6 and lifting the company’s market value to just under $100 billion. Q3 revenue rose nearly 8% to $102.9 billion, but a $5.7 billion goodwill impairment drove a GAAP net loss of almost $4 billion. CEO David Joyner will become board chair. CVS reached a $37.8 million federal settlement over insulin pen dispensing.